Phase
Condition
Vascular Diseases
Circulation Disorders
Collagen Vascular Diseases
Treatment
FDG PET/CT
Clinical Study ID
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age ≥ 50 years, capable and willing to provide informed consent and can toleratePET/CT.
ESR ≥ 50 mm/h and/or CRP ≥ 10mg/L within 1 week of PET/CT referral.
New suspected giant cell arteritis according to at least one of the followingcriteria:
Cranial GCA symptoms (new-onset localized headache, scalp or temporal artery tenderness, ischemia-related vision loss, masseter pain on prolonged mastication) PMR symptoms: shoulder and/or hip girdle pain associated with inflammatory stiffness.
Suspected large-vessel vasculitis based on angiography, MRA, or CTA.
Exclusion
Exclusion Criteria:
Initiation of corticosteroid or immunosuppressive therapy >4 days before PET/CT.
Prior TAB or treated GCA with suspected relapse.
Non-fasting or hyperglycemia (>11.1 mmol/L) resulting in altered FDGbiodistribution.
Study Design
Connect with a study center
Jewish General Hospital
Montréal, Quebec H4R3E8
CanadaSite Not Available
Hôpital du Sacré-Cœur de Montréal
Montreal 6077243, Quebec 6115047 H4J 1C5
CanadaSite Not Available
Jewish General Hospital
Montreal 6077243, Quebec 6115047 H4R3E8
CanadaSite Not Available
CHUS
Sherbrooke 6146143, Quebec 6115047 H3T1C5
CanadaSite Not Available
Université Bourgogne Europe, Centre Georges-François Leclerc
Dijon 3021372, 21000
FranceSite Not Available
University Medical Center Groningen
Groningen 2755251,
NetherlandsSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.